Lunaphore’s tumor analysis system LabSatTM detects and classifies tumors more quickly and reliably than existing solutions. The microfluidic system, developed through doctoral research at EPFL, is designed for use by research labs, pharmaceutical companies and hospitals. It hits the market today.
Test results in just minutes
With LabSatTM, tumor biopsy results are available in a matter of minutes rather than hours. This is the first product that the company has marketed since its founding in 2014.
The underlying technology is immunohistochemistry, which is widely used in diagnostic practice. It identifies tumor-specific biomarkers in a given tissue sample. The tissue sample is stained with labeled antibodies and then viewed under a microscope. Researchers can then visually ascertain the presence and location of any tumor-specific biomarkers. This process normally takes several hours.
The system was designed at
Lunaphore, which is based at EPFL Innovation Park, has raised 11.3 million francs so far – 5.3 million of which in August 2018. The company has been awarded a number of Swiss and international awards, including Venture Kick, PERL award, Venture, Venture Leaders and Science for Life.
Photo: Ata Tuna Ciftlik, CEO of the spin-off Lunaphore. His PhD theses is the starting point of the device developped by Lunaphore.
Entitle is a pioneering privilege management solution that discovers, manages, and automates just-in-time (JIT) access and modern identity governance and…
Available freely to Samtec customers under NDA, SIBORG (Signal Integrity Breakout Region Guru) works with Ansys HFSS 3D Layout to…
Entire NR1 system purpose-built for a more affordable AI infrastructure allowing for faster deployment; furthering AI’s reach into more parts…
Following rapid growth in its customer base to over 400, funding will fuel further AI development and create a hybrid…
The addition of EA’s high-efficiency regenerative power supplies greatly expands Tektronix’s trusted offering Tektronix, Inc, a leading provider in test…
Melexis reveals its groundbreaking Induxis® switch, the MLX92442. Contactless, magnet-free, and strayfield immune, this monolithic solution directly detects conductive targets.…